We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Isothermal Amplification Based COVID-19 Test System Could Detect Any Coronavirus Variant

By LabMedica International staff writers
Posted on 29 Dec 2021
Print article
Illustration
Illustration

Researchers have developed a strategy to create a cheap and rapid COVID-19 test based on isothermal amplification that will make it possible to create universal test systems for any of the COVID-19 variants.

The strategy developed by researchers at the HSE University (Moscow, Russia) will decrease the cost of COVID-19 tests considerably and speed up the process, since no specially trained professionals or expensive equipment will be needed. There are several options for systems that detect traces of SARS-CoV-2 in human blood or secretion samples. They usually detect either scraps of COVID-19’s pathogen RNA using polymerase chain reaction (PCR) and its analogues, or antibodies to COVID-19. Usually, quite a lot of time is required for such a test, from 30 minutes to several hours, which is why researchers are looking for new, faster methods to detect antibodies or COVID infection.

The Russian researchers have been working on another alternative to PCR tests that is based on so-called loop-mediated isothermal amplification (LAMP). This testing approach allows for multiplication of certain DNA or RNA fragments from bio samples with the use of special markers and ferments of extremophilic bacteria that reside in hot springs. The key advantage of LAMP over PCR is that all reactions can be made at the same temperature. This simplifies and speeds up the process. But these systems are much more complicated to develop and have a few drawbacks, which has previously limited their use in COVID-19 test systems. The new strategy developed by the researchers will help overcome these drawbacks and give healthcare professionals an opportunity to use LAMP testing to detect traces of any COVID variants in samples of mucus and blood without preliminary processing in a laboratory.

Related Links:
HSE University 

Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.